Cargando…
Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China
BACKGROUND: Lifestyle and dietary changes reflect an ongoing epidemiological transition in China, with cardiovascular disease (CVD) playing an ever-increasing role in China’s disease burden. This study assessed the burden of CVD and the potential value of lipid and blood pressure control strategies...
Autores principales: | Stevens, Warren, Peneva, Desi, Li, Jim Z., Liu, Larry Z., Liu, Gordon, Gao, Runlin, Lakdawalla, Darius N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862139/ https://www.ncbi.nlm.nih.gov/pubmed/27165638 http://dx.doi.org/10.1186/s12913-016-1420-8 |
Ejemplares similares
-
Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
por: Shahabi, Ahva, et al.
Publicado: (2017) -
Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia
por: Shafrin, Jason, et al.
Publicado: (2016) -
Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018
por: Lakdawalla, Darius, et al.
Publicado: (2021) -
Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK
por: Danese, Mark D, et al.
Publicado: (2016) -
A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE)
por: Lakdawalla, Darius N., et al.
Publicado: (2021)